DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)
South Korea · Delayed Price · Currency is KRW 3,595.00
+255.00 (7.63%)
At close: Aug 11, 2026
DAIHAN Scientific Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 83,012 | 81,118 | 71,694 | 73,702 | 72,280 | 66,281 |
Revenue Growth | 12.96% | 13.14% | -2.72% | 1.97% | 9.05% | 7.76% |
Gross Profit Gross Profit Growth | 22,842 | 22,360 | 19,763 | 22,076 | 21,458 | 18,357 |
Operating Income Operating Income Growth | 5,576 | 5,531 | 4,225 | 6,167 | 7,224 | 5,865 |
Net Income Net Income Growth | 3,308 | 3,281 | 2,693 | 3,845 | 4,702 | 3,767 |
Earnings Per Share EPS Growth | 482.45 | 478.35 | 386.00 | 543.00 | 657.00 | 523.98 |
EPS Growth | 25.12% | 23.93% | -28.91% | -17.35% | 25.39% | 121.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 16,190 | 16,121 | 13,376 | 12,811 | 10,115 | 9,340 |
Total Debt Total Debt Growth | 1,102 | 571.01 | 2,168 | 2,881 | 3,103 | 2,675 |
Net Cash (Debt) Net Cash Growth | 15,087 | 15,550 | 11,208 | 9,930 | 7,012 | 6,665 |
Net Cash Growth | 54.11% | 38.74% | 12.87% | 41.60% | 5.21% | -7.24% |
Net Cash Per Share Net Cash Per Share Growth | 2200.64 | 2266.86 | 1606.70 | 1402.79 | 979.98 | 926.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,766 | 5,444 | 3,987 | 4,793 | 4,512 | 4,132 |
Capital Expenditures CapEx Growth | -420.23 | -315.25 | -440.22 | -624.25 | -3,039 | -3,192 |
Free Cash Flow Free Cash Flow Growth | 6,346 | 5,128 | 3,547 | 4,169 | 1,474 | 939.76 |
Free Cash Flow Growth | 51.47% | 44.57% | -14.90% | 182.87% | 56.81% | -78.43% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.52% | 27.57% | 27.57% | 29.95% | 29.69% | 27.70% |
Operating Margin | 6.72% | 6.82% | 5.89% | 8.37% | 9.99% | 8.85% |
Pretax Margin | 6.94% | 6.98% | 6.35% | 8.72% | 10.40% | 9.21% |
Profit Margin | 3.98% | 4.04% | 3.76% | 5.22% | 6.50% | 5.68% |
FCF Margin | 7.64% | 6.32% | 4.95% | 5.66% | 2.04% | 1.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 125.000 | - | - | 60.000 | 60.000 | 60.000 |
Dividend Per Share Growth | 108.33% | - | - | 0% | 0% | 0% |
Dividend Yield | 3.74% | - | - | 0.99% | 0.92% | 0.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.45 | 10.92 | 12.82 | 12.17 | 10.84 | 19.49 |
P/FCF Ratio | 4.22 | 6.99 | 9.73 | 11.23 | 34.59 | 78.11 |
PS Ratio | 0.32 | 0.44 | 0.48 | 0.64 | 0.71 | 1.11 |